Clinical Trial Update: A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE) [Phase 3]

View source ↗

Summary

This update outlines a Phase 3 clinical trial evaluating the long-term safety and efficacy of belimumab in adults with interstitial lung disease associated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease-associated Interstitial Lung Disease
• Interstitial Lung Disease
• Systemic Sclerosis

Drugs mentioned

• BENLYSTA (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Connective Tissue Diseases | Phase 3 | Status: RECRUITING